Air Force Medical Research and Development
Active
- Assistance listing
- 12.810
- Agency
-
Air Force
Department of Defense
- Grant awards
- 3 $13,733,144 in federal obligations
Program facts
- Assistance type
-
- Cooperative Agreement
- Treasury account
-
- 97-0130-7-1-833
- More information
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Department of the Air Force operates the Air Force Medical Research and Development program (CFDA 12.810) to enhance the health, safety, readiness, and performance of Air Force personnel through applied medical research and advanced development, with the most recent grant award issued September 21, 2017. This program is not currently active for new competitive applications; no grant opportunities have been posted since 2017. The portfolio contains only three total awards disbursed between 2015 and 2017, indicating minimal recent funding activity.
Funded projects have targeted medical device development and commercialization with direct Air Force application: advanced trauma and hemorrhage management products, cardiovascular diagnostic equipment, and vector-borne disease assay panels. All three awards in the portfolio were Cooperative Agreements, reflecting the program's emphasis on joint development work between the Air Force and recipient organizations.
The Department of the Interior Departmental Offices Interior Business Center administered all funding under this CFDA, obligating $13.7 million total across three awards. Recent award magnitudes have ranged from approximately $3.4 million to $7.0 million per cooperative agreement. The largest single award, $7.0 million, funded transition of advanced trauma, hemorrhage, and vascular injury products with a completion target of September 2019. A second award of $3.2 million supported development of assay panels for vector-borne disease detection, concluding August 2022. A third award of $3.4 million funded advanced development and commercialization of a cardiovascular sonospectrographic analyzer through May 2018.
Applicants must be institutions or organizations; individual applications are not accepted. Work efforts are normally expected to conclude within 36 months of award. The program evaluates proposals through merit-based competitive procedures using Broad Agency Announcements or Program Announcements posted on Grants.gov, with ranking based on military relevance and scientific merit. No open solicitation is currently advertised.
Objective and description
- Objective
To enhance the health, safety, readiness, and performance of Air Force personnel through applied medical research and advanced development executed largely through grants, cooperative agreements, and contracts with civilian educational and research i
- Description
Department of the Air Force (DAF) Medical Research and Development.
Eligibility
- Applicant eligibility
Applicants must be an institution/organization. Applications will not be accepted from individuals.
- Beneficiary eligibility
Applicants must be an institution/organization. Applications will not be accepted from individuals.
- Uses of assistance
Recipients are required to conform to their accepted research protocol and are usually required to submit some form of annual or project report. Project support is limited to research and development aimed at sustaining or enhancing the technology base or understanding a biological- medical process, thereby providing a technological edge in solving complex biological-medical problems and countering future military medical threats.
- Length and time phasing of assistance
Assistance programs are normally available for work efforts that will be concluded within 3 years (36 months) from the date of award.
How to apply
- Preapplication coordination
See funding announcement
- Criteria for selecting proposals
Proposals are selected for funding based on the evaluation criteria listed in the Command's Broad Agency Announcement (BAA) or Program Announcements (PAs). The BAA and PAs can be viewed at the Grants.gov website.
- Award procedure
Merit-based competitive procedures are utilized in accordance with notices of funding opportunities, such notices are typically called Program Announcements (PAs) or Broad Agency Announcements (BAAs). Proposals are evaluated by in-house committee and extramural review committees against the evaluation criteria listed in the Broad Agency Announcement (BAA) or Program Announcement (PA). The final stage of evaluation is the establishment of an order of merit in which all competing proposals are ranked on the basis of their respective military relevance and scientific merit evaluations. Award amount will be negotiated with those proposals recommended for funding. Awards depend upon the availability of funds and the priority which the Air Force determines to exist at the time of award.
- Renewals
Once a grant or cooperative agreement is awarded, any follow-on research proposal is treated as a new request. Follow-on work should allow for the review time noted above.
Grant opportunities
| Opportunity | Status | Posted | Applications due |
|---|---|---|---|
| Notice of Intent | Closed |
Grant awards
| Award | Recipient | Federal obligations | Awarded |
|---|---|---|---|
| Development of assay panel for vector-borne disease | Biomeme, Inc. | $3,238,339 | |
| Transition of advanced trauma, hemorrhage and vascular injury products | Military Health Research Foundation, Inc. | $7,046,034 | |
| Advanced development & commercialization of the cardiovascular sonospectrographic analyzer (CSA) | Military Health Research Foundation, Inc. | $3,448,771 |
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | Military Health Research Foundation, Inc. | $10,494,805 | 76% |
| 2 | Biomeme, Inc. | $3,238,339 | 24% |
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2023 | -$899,809 |
| FY2021 | $899,809 |
| FY2020 | $380,714 |
| FY2019 | $627,620 |
| FY2018 | $1,605,573 |
| FY2017 | $7,267,076 |
| FY2016 | $2,953,385 |
| FY2015 | $898,776 |
Quick answers
What is Assistance Listing 12.810?
Assistance Listing 12.810 is Air Force Medical Research and Development, a federal grant program run by Air Force (Department of Defense).
What is the CFDA number for Air Force Medical Research and Development?
Its CFDA number is 12.810: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 12.810 awarded?
3 grant awards under 12.810 have obligated $13,733,144 in federal funds to 2 recipients.
Who receives the most funding from 12.810?
The recipients obligated the most under Air Force Medical Research and Development are Military Health Research Foundation, Inc. ($10,494,805) and Biomeme, Inc. ($3,238,339).
Are there open grant opportunities under 12.810?
No opportunity listed under 12.810 is open now. The latest, Notice of Intent, was posted on July 31, 2017.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program